Your browser doesn't support javascript.
loading
Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model.
Borst, Gerben R; Kumareswaran, Ramya; Yücel, Hatice; Telli, Seyda; Do, Trevor; McKee, Trevor; Zafarana, Gaetano; Jonkers, Jos; Verheij, Marcel; O'Connor, Mark J; Rottenberg, Sven; Bristow, Robert G.
Affiliation
  • Borst GR; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
  • Kumareswaran R; Departments of Medical Biophysics and Radiation Oncology, University of Toronto, Toronto, Canada.
  • Yücel H; Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Department of Radiation Oncology, Amsterdam, The Netherlands.
  • Telli S; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
  • Do T; Departments of Medical Biophysics and Radiation Oncology, University of Toronto, Toronto, Canada.
  • McKee T; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
  • Zafarana G; Departments of Medical Biophysics and Radiation Oncology, University of Toronto, Toronto, Canada.
  • Jonkers J; Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Department of Radiation Oncology, Amsterdam, The Netherlands.
  • Verheij M; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
  • O'Connor MJ; Departments of Medical Biophysics and Radiation Oncology, University of Toronto, Toronto, Canada.
  • Rottenberg S; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
  • Bristow RG; Departments of Medical Biophysics and Radiation Oncology, University of Toronto, Toronto, Canada.
Oncotarget ; 8(50): 87638-87646, 2017 Oct 20.
Article in En | MEDLINE | ID: mdl-29152107

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Oncotarget Year: 2017 Document type: Article Affiliation country: Canada Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Oncotarget Year: 2017 Document type: Article Affiliation country: Canada Country of publication: United States